HOB Biotech GroupLtd 대차 대조표 상태
재무 상태 기준 확인 6/6
HOB Biotech GroupLtd has a total shareholder equity of CN¥806.0M and total debt of CN¥105.1M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are CN¥1.0B and CN¥196.8M respectively. HOB Biotech GroupLtd's EBIT is CN¥41.6M making its interest coverage ratio 35.5. It has cash and short-term investments of CN¥105.1M.
주요 정보
13.0%
부채 비율
CN¥105.05m
부채
| 이자 보상 비율 | 35.5x |
| 현금 | CN¥105.13m |
| 주식 | CN¥806.03m |
| 총 부채 | CN¥196.80m |
| 총 자산 | CN¥1.00b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08
Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price
Jul 04HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem
May 06Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%
Mar 08재무 상태 분석
단기부채: 688656's short term assets (CN¥282.5M) exceed its short term liabilities (CN¥184.0M).
장기 부채: 688656's short term assets (CN¥282.5M) exceed its long term liabilities (CN¥12.8M).
부채 대 자본 내역 및 분석
부채 수준: 688656 has more cash than its total debt.
부채 감소: 688656's debt to equity ratio has reduced from 29% to 13% over the past 5 years.
부채 범위: 688656's debt is well covered by operating cash flow (102.3%).
이자 보장: 688656's interest payments on its debt are well covered by EBIT (35.5x coverage).